These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1718052)

  • 1. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
    Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
    Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
    Pontiggia L; Steiner B; Ulrichts H; Deckmyn H; Forestier M; Beer JH
    Thromb Haemost; 2006 Dec; 96(6):774-80. PubMed ID: 17139372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP; Kalafatis M; Piétu G; Lavergne JM; Chopek MW; Edgington TS; Meyer D
    Blood; 1986 May; 67(5):1356-66. PubMed ID: 3008890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets have more than one binding site for von Willebrand factor.
    Ruggeri ZM; De Marco L; Gatti L; Bader R; Montgomery RR
    J Clin Invest; 1983 Jul; 72(1):1-12. PubMed ID: 6223940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen.
    Ruan CG; Du XP; Xi XD; Castaldi PA; Berndt MC
    Blood; 1987 Feb; 69(2):570-7. PubMed ID: 3801672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations.
    Yamamoto N; Kitagawa H; Tanoue K; Yamazaki H
    Thromb Res; 1985 Sep; 39(6):751-9. PubMed ID: 2417361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
    Chang MC; Lin HK; Peng HC; Huang TF
    Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib.
    George JN; Torres MM
    Blood; 1988 May; 71(5):1253-9. PubMed ID: 3258766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.
    Kawasaki T; Taniuchi Y; Hisamichi N; Fujimura Y; Suzuki M; Titani K; Sakai Y; Kaku S; Satoh N; Takenaka T
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):947-53. PubMed ID: 8948455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor.
    Ozaki Y; Satoh K; Yatomi Y; Miura S; Fujimura Y; Kume S
    Biochim Biophys Acta; 1995 Apr; 1243(3):482-8. PubMed ID: 7537105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites.
    Mohri H; Yoshioka A; Zimmerman TS; Ruggeri ZM
    J Biol Chem; 1989 Oct; 264(29):17361-7. PubMed ID: 2477370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
    Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
    Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
    Kupinski JM; Miller JL
    Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.